Navigation Links
AdvaMed Releases New Survey Results on DTC Campaigns
Date:10/14/2009

WASHINGTON, Oct. 14 /PRNewswire-USNewswire/ -- The Advanced Medical Technology Association (AdvaMed), the leading trade association representing America's medical technology companies, today released results from a snapshot survey with Porter Novelli about direct-to-consumer (DTC) marketing initiatives, during a panel discussion on the topic at the third annual AdvaMed 2009 conference.

The goal of the survey is to assess how medical device companies are conducting DTC marketing initiatives. Of survey respondents, an overwhelming majority of DTC marketing campaigns, 94 percent, are focused on patient benefit materials, such as patient educational brochures, with the majority of existing advertising campaigns coming from print advertising. Although more traditional media outlets still constitute the majority of activities, the survey results reveal social media is still a fairly new phenomenon in comparison to existing DTC marketing campaigns.

The panel highlighted the importance of using DTC marketing campaigns to encourage discussion between patients and healthcare professionals and the need to clearly communicate the consumer risks and benefits of medical technology. Attendees also heard how to incorporate the new AdvaMed DTC advertising guiding principles into successful consumer awareness campaigns.

"DTC marketing and advertising can be particularly helpful in raising awareness of new lifesaving and life-enhancing technologies and underutilized medical technology," said Tony Blank, participating panelist, and vice president, cardiovascular regulatory affairs, Boston Scientific Corporation. "Industry is committed to supporting responsible DTC advertising and AdvaMed's guiding principles when developing campaigns to ensure both benefit and risk information is presented to patients in a clear and understandable manner."

"When direct-to-consumer marketing enhances the public health, that's smart and savvy communications," said Peter Pitts, participating panelist, and partner and director, global health, Porter Novelli.

Designed by industry and for industry, AdvaMed 2009 is the premier MedTech conference for CEOs, business executives, policy-makers, members of the media, financiers, and service providers and other MedTech leaders from around the world. In only its second year, AdvaMed 2008 attracted 1,400 industry leaders including 500+ CEOs, Presidents and C-Level executives.

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.

SOURCE AdvaMed and AdvaMed 2009


'/>"/>
SOURCE AdvaMed and AdvaMed 2009
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Vibrant Exhibit Hall Features Innovative Medical Technology at AdvaMed 2009
2. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
3. Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference
4. CEL-SCI Corporation Releases Letter to Shareholders
5. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
6. Velos, Inc. Releases Software to Support Cancer Centers With New Workflow and Content for NCI Clinical Trials Reporting Program
7. CEL-SCI Corporation Releases Letter to Shareholders
8. CEL-SCI Corporation Releases Letter to Shareholders
9. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
10. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
11. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 2017 On Friday, benchmark US ... closed the trading session up 0.19%; the Dow Jones ... was down 0.08%. US markets made broad based gains ... in green. Pre-market today, Stock-Callers.com reviews these four Medical ... WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group Inc. (NASDAQ: ...
(Date:3/27/2017)... , March 27, 2017  Impax Laboratories, Inc. (NASDAQ: ... Paul M. Bisaro as Impax,s President and ... Board, effective March 27, 2017. Mr. Bisaro will succeed ... Interim President and Chief Executive Officer since December of ... and branded pharmaceutical experience, Mr. Bisaro, 56, is an ...
(Date:3/27/2017)... , March 27, 2017 Arena Pharmaceuticals, Inc. ... on developing novel, small molecule drugs across multiple therapeutic areas, ... Chief Executive Officer, will present a corporate update at the ... 3:40pm ET.  The conference will take place April 4-5, 2017 ... New York , NY.  A live ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... 27, 2017 , ... Drs. Bruce Trimble and Michelle Parker ... a referral. Trimble Dental offers a variety of services to meet each patient’s ... patients have discolored, crooked or missing teeth in Eau Claire, WI, Drs. Trimble ...
(Date:3/27/2017)... Austin, TX (PRWEB) , ... March 27, 2017 , ... ... , Edward Buckingham MD, and his colleague, Sudeep Roy, MD, was recently published ... on Bipolar Electrocautery Efficacy in Rhytidectomy” details Drs. Buckingham and Roy’s study on the ...
(Date:3/27/2017)... ... 27, 2017 , ... The Case Management Society of America (CMSA) will install ... CMSA’s membership has elected their upcoming President-Elect, Secretary, Treasurer and two Directors to ... new VA Advisory position has also been added to the BOD, per an appointment ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek ... to pursue the recent RNA methylation “gold rush” with their established portfolio of ... newfound characteristics of N6-methyladenosine, or m6A , RNA methylation has received a ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Anaheim Hills office ... First National Capital has added 10 new sales professionals over the past 6 months ... by 15 additional new hires over the course of 2017. , “This new ...
Breaking Medicine News(10 mins):